Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention

被引:16
|
作者
Jiao, Yungen [1 ,2 ]
Hu, Feng [2 ]
Zhang, Zhengang [2 ]
Gong, Kaizheng [2 ]
Sun, Xiaoning [2 ]
Li, Aihua [2 ]
Liu, Naifeng [1 ]
机构
[1] Southeast Univ, Sch Med, Dept Cardiol, Inst Cardiovasc Dis,Zhongda Hosp, Nanjing 210000, Jiangsu, Peoples R China
[2] Yangzhou Univ, Clin Med Sch 2, Dept Cardiol, Peoples Hosp Yangzhou 1, Yangzhou 225400, Peoples R China
基金
中国国家自然科学基金;
关键词
DENSITY-LIPOPROTEIN RECEPTOR-1; C-REACTIVE PROTEIN; ATORVASTATIN; PREVENTION; DISEASE;
D O I
10.1007/s40261-015-0335-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives The aim of this work was to investigate the efficacy and safety of loading-dose rosuvastatin therapy in elderly patients with non-ST-segment elevation acute coronary syndromes (NSTEACS) undergoing elective percutaneous coronary intervention (PCI). Methods A total of 126 patients (>= 70 years old) with NSTEACS were randomly divided into two groups: (1) loading-dose rosuvastatin-treated group, treated with rosuvastatin 20 mg 12 h prior to PCI, with a second dose administered just before PCI (n = 62), and (2) control-treated group, treated with the standard method according to ACC/AHA guidelines in UAP/NSTEMI 2007 (n = 64). All patients were required to take rosuvastatin 10 mg once a day starting 24 h after the surgery irrespective of the initial randomization assignment. The serum soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLox-1), high-sensitivity C-reactive protein (hs-CRP), creatinine kinase (CK)-MB, cardiac troponin I (cTnI), and brain natriuretic peptide (BNP) levels were measured prior to PCI and at 24 h and 30 days after PCI in both groups. The left ventricular ejection fraction (LVEF) levels were recorded prior to PCI and 30 days after PCI in both groups. Results Compared to pre-PCI, the serum sLox-1, hs-CRP, CK-MB, and cTnI levels were increased at 24 h after PCI (all p < 0.05) in both groups. However, the increased sLox-1, hs-CRP, CK-MB, and cTnI values were significantly lower in the loading-dose rosuvastatin-treated group than in the control-treated group (p < 0.05). In addition the serum sLox-1 and hs-CRP levels were lower in the loading-dose rosuvastatin-treated group than in the control-treated group at 30 days after PCI. However, the decreased values of sLox-1and hs-CRP from 24 h after PCI to 30 days after PCI did not show any significant difference between the two groups. No significant difference was found in the serum ALT and Scr levels between the two groups before and after PCI. Compared to the control-treated group, the serum BNP level decreased (p < 0.05) and LVEF (p < 0.05) increased in the loading-dose rosuvastatin-treated group at 30 days after PCI. Conclusion The loading-dose rosuvastatin therapy in elderly patients with non-ST-segment elevation acute coronary syndromes undergoing elective PCI can attenuate the increase in serum hs-CRP, sLox-1, CK-MB, and cTnI levels, reduce myocardial injury and inflammatory reaction caused by PCI, and improve the LVEF level at 30 days after PCI, ensuring an effective and safe therapy.
引用
收藏
页码:777 / 784
页数:8
相关论文
共 50 条
  • [1] Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention
    Yungen Jiao
    Feng Hu
    Zhengang Zhang
    Kaizheng Gong
    Xiaoning Sun
    Aihua Li
    Naifeng Liu
    [J]. Clinical Drug Investigation, 2015, 35 : 777 - 784
  • [2] Safety and efficacy of high loading-dose clopidogrel therapy in patients undergoing percutaneous coronary intervention
    Rha, SW
    Cheon, BW
    Kim, HH
    Moon, SK
    Kim, JW
    Hong, SJ
    Park, CG
    Seo, HS
    Oh, DJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (8A): : 74A - 74A
  • [3] Effect of a Single High Loading Dose of Rosuvastatin on Percutaneous Coronary Intervention for Acute Coronary Syndromes
    Wang, Zhengzhong
    Dai, Hongyan
    Xing, Mingqing
    Yu, Zhongxiang
    Lin, Xianru
    Wang, Shoudong
    Zhang, Junyi
    Hou, Fangjie
    Ma, Ying
    Ren, Yongqiang
    Tan, Kai
    Wang, Yanping
    Ge, Zhiming
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 18 (04) : 327 - 333
  • [4] Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention Reply
    Siller-Matula, Jolanta M.
    Jilma, Bernd
    [J]. HEART, 2011, 97 (13) : 1111 - 1112
  • [5] The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome
    Luo, Jun
    Li, Jiang
    Shen, Xiangqian
    Hu, Xinqun
    Fang, Zhenfei
    Lv, Xiaolin
    Zhou, Shenghua
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) : 2350 - 2353
  • [6] Prasugrel as Antiplatelet Therapy in Patients With Acute Coronary Syndromes or Undergoing Percutaneous Coronary Intervention
    Fletcher, Barbara
    Thalinger, Karen K.
    [J]. CRITICAL CARE NURSE, 2010, 30 (05) : 45 - 54
  • [7] The effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome
    Yun, Kyeong Ho
    Jeong, Myung Ho
    Oh, Slack Kyu
    Kim, Yun Kyung
    Park, Eon Mi
    Yoo, Nam Jin
    Kim, Nam-Ho
    Ahn, Youngkeun
    Jeong, Jin Won
    [J]. CIRCULATION, 2006, 114 (18) : 815 - 815
  • [8] The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention
    那堃
    [J]. China Medical Abstracts (Internal Medicine), 2022, (01) : 31 - 31
  • [9] Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Fioretti, Vincenzo
    Sperandeo, Luca
    Gerardi, Donato
    Di Fazio, Aldo
    Stabile, Eugenio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [10] Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Florentin, Matilda
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (04) : 839 - 842